Tata Memorial Centre
65
35
42
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
4.6%
3 terminated/withdrawn out of 65 trials
75.0%
-11.5% vs industry average
9%
6 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (65)
Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
Role: lead
Palliative Radiation for Advanced Cervical Cancer
Role: collaborator
Short Versus Long-term Levetiracetam in Brain Tumors
Role: lead
Phase II Trial of Immunonutrition in Hepatectomy
Role: lead
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
Role: lead
BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM
Role: lead
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Role: lead
SCRT in TNT With or Without Chlorophyllin
Role: lead
Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
Role: lead
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
Role: lead
Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant
Role: lead
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia
Role: lead
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
Role: collaborator
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
Role: lead
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
Role: lead
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
Role: lead
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Role: lead
Tracing Brain Tumors Through Deep Time
Role: lead
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
Role: lead
Radiation Therapy in Unresectable Gall Bladder Cancer
Role: lead